EuroIntervention PCRonline - Connecting with the community

Just accepted article

Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Aarhus University Hospital, Department of Cardiology, Aarhus N, DENMARK; 2. Department of Cardiology, Aarhus University Hospital, Denmark; 3. Department of Cardiology, Aarhus University Hospital, Denmark; 4. Department of Cardiology, Aarhus University Hospital, Denmark; 5. Department of Neurology, Aarhus University Hospital, Denmark; 6. Aarhus University Hospital, Department of Cardiology, Aarhus N, DENMARK

Abstract

Aims: To evaluate safety and efficacy of left atrial appendage occlusion (LAAO) with the Amplatzer Cardiac Plug (ACP) or Amulet using Aspirin (ASA) alone as post-implant antithrombotic treatment.

Method: Single-center, prospective, non-randomized study on LAAO with the ACP or Amulet in a consecutive cohort (n=110) treated by ASA alone post-implantation. Primary outcome was device-related thrombosis, while secondary outcomes were ischemic stroke or major bleeding. Clinical follow-up was conducted after 6 weeks and 12 months with TEE and cardiac CT. RESULTS 107 patients…

– OR –